Senior Medical Director, Head MACS HaemophiliaSobiBasel, Basel-Stadt, Switzerland
PB0201 - Efanesoctocog Alfa Versus Extended Half-Life Factor VIII Therapies for Prophylaxis in Adolescents and Adults with Severe Hemophilia A: A Matching-Adjusted Indirect Comparison and Meta-Analysis
Sunday, June 25, 202318:30 – 19:30 ET
PB0638 - Final data from A-MOVE: 12-Month Prospective Multicentre Study to Investigate the Impact of Systematic Joint Examination on Treatment Management Decisions in Patients with Hemophilia A in France
Monday, June 26, 202318:30 – 19:30 ET
